Show simple item record

Files in this item

Restricted Access
dc.contributor.advisorSmith, Coleman
dc.creator
dc.date.accessioned2021-09-23T21:08:29Z
dc.date.created2021
dc.date.issued
dc.date.submitted01/01/2021
dc.identifier.uri
dc.descriptionM.S.
dc.description.abstractHepatitis C Virus (HCV) infected donor kidneys have increased due to the opioid epidemic and are now used for HCV viremic donor kidney transplants. For the patients who receive the viremic donor kidney, they are treated for HCV postrenal transplant. This study assessed the association between race and hospital readmission post viremic donor kidney transplant. 52 subjects had an HCV viremic donor kidney transplant between 2019 and 2020 and Medstar Georgetown University Hospital. The study was consisted of (58%) African Americans and (69%) were males. A small number of patients already had HCV at transplant. (19%). A 29% were readmitted for an inpatient stay thirty days post-transplant. (15/52 patients). It was found that there is no statically significant difference between African Americans and Non-African Americans who have had an HCV viremic donor kidney transplant.
dc.formatPDF
dc.format.extent29 leaves
dc.languageen
dc.publisherGeorgetown University
dc.sourceGeorgetown University-Graduate School of Arts & Sciences
dc.sourceEpidemiology
dc.subject.lcshEpidemiology
dc.subject.otherEpidemiology
dc.titleAfrican Americans, Hospitalization, and Hepatitis C Viremic Positive Donor Kidneys: A Retrospective Study
dc.typethesis
gu.embargo.lift-date2022-03-23
gu.embargo.termscommon-6-months


This item appears in the following Collection(s)

Show simple item record